Vijaya Diagnostic Centre Limited — Investor Meet, 13-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Vijaya Diagnostic delivered robust Q4 FY26 results: revenue up 26.6% YoY to INR 219 Cr and EBITDA surged 38.7% to INR 95.5 Cr, hitting a 43.5% margin. Full-year revenue crossed INR 814 Cr, growing 19.5% with 41.4% EBITDA. Growth drivers include strong pathology/radiology, wellness momentum, and network expansion. Management plans 4-5 new hubs, 10-12 spokes, and an automated lab in FY27 (capex INR 140-150 Cr). New hubs in core markets are breakeven faster. The company remains focused on volume-led growth, densifying new geographies like Pune, Kolkata, and Bangalore, while targeting over 40% EBITDA margins. Confident outlook on sustained value creation.